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AbstrACt
Objective Guidelines recommend non-invasive 
ischaemia testing (NIIT) for the majority of patients with 
suspected ischaemic heart disease in a non-emergency 
setting. A substantial number of these patients undergo 
diagnostic coronary angiography (CA) without therapeutic 
intervention inappropriately due to lacking preceding 
NIIT. The aim of this study was to evaluate the effect of 
voluntary healthcare models with limited access on the 
proportion of patients without NIIT prior to elective purely 
diagnostic CA.
Design Retrospective cross-sectional analysis of 
insurance claims data from 2012 to 2015. Data included 
claims of basic and voluntary healthcare models from 
approximately 1.2 million patients enrolled with the 
Helsana Insurance Group. Voluntary healthcare models 
with limited health access are divided into gate keeping 
(GK) and managed care (MC) capitation models. Inclusion 
criteria: patients undergoing CA. Exclusion criteria: 
Patients<18 years, incomplete health insurance data 
coverage, acute cardiac ischaemia and emergency 
procedures, therapeutic CA (coronary angioplasty/stenting 
or coronary artery bypass grafting). The effect of voluntary 
healthcare models on the proportion of NIIT undertaken 
within 2 months before diagnostic CA was assessed by 
means of multiple logistic regression analysis, controlled 
for influencing factors.
results 9173 patients matched inclusion criteria. 33.2% 
(3044) did not receive NIIT before CA. Compared with basic 
healthcare models, MC was independently associated with 
a higher proportion of NIIT (p<0.001, OR 1.17, CI 1.045 
to 1.312), when additionally controlled for demographics, 
insurance coverage, inpatient treatment, cardiovascular 
medication, chronic comorbidities, high-risk status 
(patients with therapeutic cardiac intervention 1 month 
after or 18 months prior to diagnostic CA). GK models 
showed no significant association with the rate of NIIT 
(p=0.07, OR 1.11, CI 0.991 to 1.253).
Conclusions In a non-GK healthcare system, voluntary 
MC healthcare models with capitation were associated 
with a reduced inappropriate use of diagnostic CA 
compared with GK or basic models.
IntrODuCtIOn 
Existing guidelines1–7 recommend non-invasive 
ischaemia testing (NIIT) for the majority of 
patients with suspected ischaemic heart disease 
in a non-emergency setting. Nevertheless, a 
substantial number of these patients undergo 
diagnostic coronary angiography (CA) without 
therapeutic intervention inappropriately and 
are therefore exposed to unnecessary risks 
without any clinical benefit.8–15 In a non-gate 
keeping (GK) healthcare system such as Swit-
zerland, hardly any steering mechanisms exist 
to ensure that potentially harmful and expen-
sive procedures are only performed in case of 
correct indication. The admitting physician 
(mainly general practitioner or cardiologist) 
usually sets the indication for the intervention 
and the performing invasive centres rarely 
decline assigned patients due to economic 
reasons or in order not to disagree with the 
admitting physician.
Besides the basic healthcare models, 
offering unlimited access to almost all sectors 
of the healthcare system including specialist 
and emergency care, alternative voluntary 
healthcare models with various degrees of 
strengths and limitations of this study
 ► Highly relevant topic concerning inappropriate use 
of a potentially harmful and expensive procedure 
such as the coronary angiography (CA).
 ► Only scarce data on non-emergency CA exist in liter-
ature originating from different healthcare settings.
 ► Data originate from a single health insurance group 
in Switzerland, although one of the largest in the 
country, including data on health insurance claims 
from approximately 1.2 million patients.
 ► No data on socioeconomic status and clinical infor-
mation are available.
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restriction in exchange to premium reduction can be 
chosen from. These voluntary healthcare models can be 
summarised into two main groups: (1) GK models with 
steering mechanisms, such as basic consultation of an 
insurance hotline for example and (2) managed care 
(MC) models with capitation. Previous studies showed a 
lower prevalence of potentially inappropriate medication 
use in elderly patients and a lower disease-specific hospi-
talisation rate in patients who were chronically ill enrolled 
in a MC model compared with non-MC patients.16 17 No 
data on the association between NIIT and various types of 
healthcare models in Switzerland exist.
The aim of this study was therefore to evaluate the 
effect of voluntary GK or MC healthcare models on the 
proportion of patients without NIIT prior to elective 
purely diagnostic CA without therapeutic intervention. 
The study includes a retrospective analysis of insurance 
claims data on diagnostic procedures undertaken within 
2 months before CA depending on the healthcare model.
MAterIAls AnD MethODs
setting
Swiss residents are obliged to enrol in a basic healthcare 
model, which covers all costs besides deductibles. Depending 
on the model chosen, annual deductibles for adults vary 
between 300 and 2500 Swiss Francs. A patient copayment 
of 10% of all costs up to a maximum of 700 Swiss Francs 
per year is payable independent of the chosen healthcare 
model. Currently, residents can chose a basic healthcare 
model from 53 different insurance companies. In general, 
in Switzerland, no gate-keeping system exists, meaning that 
patients have unlimited access to all healthcare providers, 
unless they are voluntarily insured in a limited access model. 
Patients agree to a restriction of choice or limited access in 
exchange of lower premiums. In such limited access models, 
the general practitioner or an insurance telephone hotline 
has to be consulted before contacting a specialist or another 
institution such as a hospital. In case of emergency, this regu-
lation is over-ruled. In Switzerland, the currently existing 
limited access models can be summarised into two types of 
models: (1) GK models with steering mechanisms, such as 
prior consultation of a telemedicine centre, for example 
and (2) MC models with capitation. In the capitation system, 
the health insurance company reimburses the healthcare 
providers, usually physician networks, with a set amount for 
each enrolled patient assigned to them per period of time, 
whether or not that person seeks care. The remuneration is 
based on the average expected healthcare utilisation of each 
individual patient, with greater payment for patients with 
significant medical history or chronic conditions. Compared 
with other healthcare systems, the Swiss system is more inpa-
tient treatment oriented due to cofinancing of inpatient 
treatments by governmental institutions.
subjects, data collection and measurements
Data for this study included health insurance claims 
from approximately 1.2 million patients, who live all over 
Switzerland and were enrolled with the Helsana Group. Data 
on patients undergoing CA in the years 2012 to 2015 were 
retrospectively analysed. Data were considered for analysis if 
insurance coverage was complete within 18 months before 
and/or 1 month after CA. A total 828 of 12 078 (6.8%) of 
patients were not considered due to incomplete coverage 
of health insurance data during the necessary observation 
period (due to, eg, change of insurance company, military 
services, death). Hence, data on 11 250 patients remained 
for analysis before exclusion criteria. Detailed TARMED 
(Standard billing rate for outpatient medical care in Swit-
zerland, version 2014) and Diagnosis Related Groups (DRG, 
version 2012) positions are specified in online supplemen-
tary appendix 1.
Inclusion criteria
 ► Diagnostic CA performed in the years 2012–2015. If 
in this time interval, patients received more than one 
CA, only the first CA was taken into consideration 
(n=11 250).
Exclusion criteria
 ► Patients<18 years.
 ► Acute cardiac ischaemia and/or emergency 
procedures.
 ► Therapeutic CA (coronary angioplasty/stenting or 
coronary artery bypass grafting).
Measurements
 ► Patient characteristics: sex, age, language area and 
type of insurance coverage (deductible class, supple-
mentary private hospital insurance, MC healthcare 
model).
 ► Setting of CA: inpatient or outpatient.
 ► NIIT performed within 2 months prior to CA 
(stress-ECG, echocardiography, stress echocardiog-
raphy, scintigraphy, CT, cardiac MRI).
 ► Cardiovascular Medication grouped according to 
Anatomical-Therapeutic-Chemical-Classification 
(ATC)18
 – Group 1: aspirin, platelet aggregation inhibitors.
 – Group 2: statins, lipid modifying agents.
 – Group 3: antihypertensives, diuretics, beta block-
ing agents, calcium channel blockers, agents acting 
on the renin-angiotensin system.
 – Group 4: antidiabetics.
 – Group 5: antianginous drugs.
 – Group 6: antithrombotics.
 ► Number of chronic conditions according to Pharma-
ceutical cost groups PCG19 20
 – Group 1: pcg_n<3 0, 1 or 2 PCGs.
 – Group 2: pcg_n<5 3 to 4 PCGs.
 – Group 3: pcg_n<7 5 to 6 PCGs.
 – Group 4: pcg_n≥7 7 or more PCGs.
Sensitivity analysis with high-risk patients
We performed a sensitivity analysis of our data by defining 
a subgroup of patients as high-risk with supposed 
cardiac disease, if having received therapeutic cardiac 
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intervention/diagnosis within 1 month after and/or 18 
months prior to diagnostic CA.
Patient and public involvement
Neither patients nor the public were involved in the study 
design.
statistical analysis
Descriptive statistical techniques (table 1) were used, to 
provide a general profile of the study population and 
grouped into totally three groups of patients: patients 
with non-limited and limited access healthcare models 
(GK and MC). The descriptive statistics were performed 
pairwise for each healthcare model separately. These data 
were presented as means in the case of continuous vari-
ables and as percentages in case of categorical variables.
Differences within the healthcare models (online 
supplementary appendix 2) with respect to the contin-
uous variable age were analysed with a non-parametric 
analysis of variance Kruskal-Wallis test. The variables with 
two levels (sex, high-risk status (patients having received 
therapeutic cardiac intervention/diagnosis within 
1 month after and/or 18 months prior to diagnostic 
CA), supplementary private hospital insurance coverage, 
language area, inpatient CA, cardiac medication class 
Table 1 Descriptive statistics of the study population grouped into non-limited and limited access healthcare models (GK and 
MC)
Non-limited access (n=5258)
Limited access (n=3915)
GK (n=1816) MC (n=2099)
No NIIT
(n=1818)
With NIIT
(n=3440)
No NIIT
(n=574)
With NIIT
(n=1242)
No NIIT
(n=652)
With NIIT
(n=1447)
High-risk (=1) 1006 1692 2 287 577 2 306 644 2
Age (mean) 68.1 (12.8) 67.6 (10.9) ** 1 66.4 (12.5) 66.9 (10.6) 1 66.6 (13.1) 66.6 (11.4) 1
Sex (female) 738 1351 2 213 483 2 254 547 2
Deductible 3 3 3
  300 1262 2355 357 743 442 962
  500 394 749 134 310 116 290
  1000 45 71 26 65 28 48
  1500 59 127 24 51 23 55
  2000 5 14 2 14 3 16
  2500 53 124 31 59 40 76
Private 493 925 2 120 288 2 142 316 2
Latin 541 1066 2 195 466 2 55 116 2
Inpatient 1166 1765 ***2 357 584 *** 441 798 ***
ATC 1 704 1738 ***2 219 648 ***2 241 732 ***2
  2 576 1216 **2 175 465 **2 195 512 *2
  3 1114 2192 2 316 755 **2 365 931 ***2
  4 277 510 2 72 152 2 80 185 2
  5 281 544 2 89 162 2 79 178 2
  6 1038 2429 ***2 319 840 ***2 348 985 ***2
PCG **3 3 3
  <3 412 768 175 372 203 444
  3–4 624 1342 200 474 221 557
  5–6 478 893 145 295 150 304
  >6 304 437 54 101 78 142
Significance no NIIT vs with NIIT within non-limited access and limited access group: ***p<0.0001, **p<0.001, *p<0.01. (1) Kruskal-Wallis test, 
(2) Fisher exact test, (3) χ² test, pairwise comparisons between NIIT and no NIIT for each health insurance model separately. ATC, Anatomical-
Therapeutic-Chemical-Classification group 1=Aspirin, platelet aggregation inhibitors, 2=statins, lipid modifying agents, 3=antihypertensives, 
diuretics, beta blocking agents, calcium channel blockers, agents acting on the renin-angiotensin system, 4=antidiabetics, 5=antianginous 
drugs, 6=antithrombotics (Categorical variable, an individual can be positive for several ATC groups); CA: coronary angiography; GK: gate 
keeping; Latin, French or Italian part of Switzerland compared to German part; High-risk patients: having received therapeutic cardiac 
intervention within one month after or 18 months prior to diagnostic CA; MC: managed care: Deductible class in Swiss Francs; NIIT: non-
invasive ischaemia testing; PCG: number of chronic conditions according to pharmaceutical cost groups; Private, supplementary private 
hospital insurance.
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according to ATC) were analysed with an exact Fisher’s 
test. The number of chronic medical conditions identi-
fied using PCG and the deductible class were compared 
with a χ² test.
We performed a logistic regression analysis to evaluate 
the independent association between receiving NIIT 
within 2 months prior to CA and the various healthcare 
models (figure 1 and table 2). In order to assess patient-
level effects, the following additional independent vari-
ables were included in the regression analysis: age, sex, 
deductible class, supplementary private hospital insur-
ance coverage, language area, inpatient CA, cardiac 
medication class according to ATC, number of chronic 
medical conditions identified using PCGs and high-risk 
status. Goodness of fit measures for the model were: 
Nagelkerke 0.05075414, BrierScore 0.2134051, C-Statistic 
0.618. The strength of associations was measured by the 
OR and the respective 95% CI. The level of significance 
was set at 0.05. All statistical analyses were performed 
using R V.3.3.1 (2016-06-21) (R Foundation for Statistical 
Computing, Vienna, Austria).21 22
ethics approval
According to the national ethical and legal regulation, an 
ethical approval was not needed. Permission to access the 
study data was provided by the Helsana Group. Since data 
were anonymised, no consent of patients was required.
results
Population
During the observed period, a total of 19 032 therapeutic 
CA performed on 14 833 patients were registered in 
the Helsana data warehouse. A total of 11 250 CA were 
eligible for analysis. According to the exclusion criteria 
(multiple exclusion criteria possible per person therefore 
the exclusions cannot be summed up), we excluded five 
patients since they were under the age of 18 years, 360 
emergency procedures, 1922 therapeutic CA (coronary 
angioplasty/stenting or coronary artery bypass grafting). 
In total, 9173 patients remained for analysis.
The descriptive statistics of the study population are 
listed in table 1. From the 9173 patients representing 
the study population, 5587 were male (60.9%, mean age 
66.4 years) and 3586 were female (39.1%, mean age 68.7 
years).
Figure 1 Distribution of NIIT performed according to 
healthcare model. OR NIIT: OR for NIIT controlled for the 
confounders age, sex, language area, insurance coverage, 
inpatient treatment, cardiovascular medication, number of 
chronic comorbidities and high-risk status. *P<0.001 (OR 
1.17) for managed care model compared with non-limited 
access model (Reference). NIIT, non-invasive ischaemia 
testing. 
Table 2 Determinants for receiving non-invasive ischaemia 
testing before coronary angiography
CI OR Sig
Age (years) 0.998 to 1.007 1.003
Sex (female) 0.967 to 1.166 1.062
Deductible Class (Swiss Francs, Reference 300)
  500 0.912 to 1.141 1.020
  1000 0.667 to 1.120 0.865
  1500 0.841 to 1.374 1.075
  2000 1.082 to 4.381 2.177 *
  2500 0.809 to 1.289 1.022
Private 1.025 to 1.267 1.140 *
French or Italian part 
of Switzerland
0.841 to 1.044 0.937
Inpatient CA 0.540 to 0.664 0.599 ***
ATC group 1–6
  1 1.251 to 1.620 1.423 ***
  2 0.922 to 1.135 1.023
  3 1.002 to 1.218 1.104 *
  4 0.851 to 1.115 0.974
  5 0.874 to 1.130 0.994
  6 1.034 to 1.356 1.184 *
PCG (reference<3)
  <5 0.940 to 1.192 1.058
  <7 0.809 to 1.064 0.928
  >=7 0.624 to 0.881 0.742 ***
Limited access models (reference non-limited access)
  Managed care 1.045 to 1.312 1.171 **
  Gate keeping 0.991 to 1.253 1.114
High-risk cardiac 
status
0.046443 0.836 ***
Sig: significance: ***p<0.0001, **p<0.001, *p<0.01. ATC: 
Anatomical-Therapeutic-Chemical-Classification group 1=Aspirin, 
platelet aggregation inhibitors, 2=statins, lipid modifying agents, 
3=antihypertensives, diuretics, beta blocking agents, calcium 
channel blockers, agents acting on the renin-angiotensin system, 
4=antidiabetics, 5=antianginous drugs, 6: antithrombotics 
(Categorical variable, an individual can be positive for several ATC 
groups); CA: coronary angiography; High-risk patients: having 
received therapeutic cardiac intervention within one month after 
or 18 months prior to diagnostic CA; PCG: number of chronic 
conditions according to pharmaceutical cost groups; Private: 
supplementary private hospital insurance.
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Patients insured in basic healthcare models were slightly 
older (67.7 (11.6) vs 66.6 (11.6) years, p<0.0001), chose 
the lowest possible deductible of 300 Francs more often 
(3617 (68.8%) vs 2504 (64.0%), p<0.001), were enrolled 
in a supplementary private hospital insurance more often 
(1418 (27.0%) vs 866 (22.1%), p<0.0001), had more 
antidiabetics (787 (15%) vs 489 (12.5%), p<0.0001) and 
antianginal medication (825 (15.7%) vs 508 (13.0%), 
p<0.0001), more PCGs (4.1 (2.1) vs 3.6 (2.0), p<0.0001) 
and had more often a high-risk status (2696 (51.3%) 
vs 1814 (46.3%), p<0.0001), compared with patients 
insured in limited access models (online supplementary 
appendix 2). Concerning the other patient characteris-
tics, no differences existed.
non-invasive ischaemia testing
A total of 3044 patients had no NIIT (1455 without and 
1599 with high-risk). Total 488 of 1445 (33.8 %) patients 
without NIIT had a conventional ECG prior to CA, and 
in the high-risk population, this was the case in 722 of 
1599 (45.2%) (p<0.0001, data not shown). The most 
NIITs stress-ECG+transthoracic echocardiography were 
performed significantly more often before CA in patients 
insured in limited access compared with non-limited 
access models (1750 (44.7%) vs 2039 (38.8%) p<0.0001 
and 2044 (52.2%) and 2528 (48.1%), p<0.0001, data 
not shown). The remaining types of NIIT were rarely 
performed and only showed a significant difference in 
the use of scintigraphy (non-limited 131 (2.5%) vs limited 
access models 64 (1.6%), p<0.001, data not shown). The 
distribution of the NIIT is depicted in online supplemen-
tary appendix 3).
Determinants for non-invasive ischaemia testing
Patients with MC models had a significantly higher OR of 
17% to receive NIIT before CA compared with patients 
with non-limited models, when controlled for the 
confounders age, sex, language area, insurance coverage, 
inpatient treatment, cardiovascular medication, number 
of chronic comorbidities and high-risk status (OR 1.17, 
p<0.001). GK models did not show any significant influ-
ence on the chance of receiving NIIT (OR 1.11, p=0.071). 
The distribution of NIIT performed according to health-
care model can be appreciated in figure 1.
Following determinants were also independently 
significantly associated with receiving NIIT: the use of 
platelet aggregation inhibitors, antithrombotic and anti-
hypertensive medication, being supplementary privately 
insured and a deductible of 2000 SFR. Following deter-
minants were significantly associated with not receiving 
NIIT: high-risk status, a high number of chronic comor-
bidities as well as inpatient treatment (table 2).
DIsCussIOn
In our study population of elective CA with no therapeutic 
consequence (no coronary angioplasty/stenting or coro-
nary artery bypass grafting), one-third did not receive 
NIIT before diagnostic CA. MC was independently signifi-
cantly associated with a higher proportion of NIIT when 
additionally controlled for potential confounders. GK 
models showed no significant association with the rate of 
NIIT.
effects of limited access healthcare models on treatment 
quality
In our study, emergency CA were excluded and the study 
population consisted of patients undergoing purely 
diagnostic elective CA with no therapeutic consequence 
(eg, no coronary angioplasty/stenting or coronary 
artery bypass grafting). The study population therefore 
represents a selection of patients with at least stable 
coronary heart disease (CHD) or no CHD at all. From a 
previous study among this selection of patients we know, 
that 37.5% did not receive any NIIT at all before elec-
tive CA with no therapeutic consequence, suggesting 
a substantial overuse of a potentially harmful and inap-
propriate diagnostic intervention.12 It has been assumed 
that patients insured in limited access healthcare models 
undergo less diagnostic procedures or interventions due 
to budget considerations, especially in capitated health-
care models. In our study, this hypothesis is clearly refuted. 
Patients with stable angina pectoris insured in limited 
access healthcare models underwent a more appropriate 
diagnostic pathway than regularly insured patients did, 
meaning in a stable clinical situation they were subjected 
to significantly more non-invasive diagnostic testing, 
therefore reducing inadequate CA. Our findings are in 
line with another study from the Swiss healthcare system, 
which also showed higher referral rates among MC 
patients compared with patients insured in basic health-
care models.23 One reason for the more appropriate 
diagnostic pathway found in MC patients might be the 
aspect of membership in a general practitioners network. 
In most parts of Switzerland, general practitioners can 
only offer MC insurance models to their patients, if they 
are member in a general practitioners network. These 
networks offer evidence-based guidelines, which the 
general practitioners are obliged to respect when initi-
ating treatment. Depending on the network, more or 
less rigorous quality control mechanisms exist to check 
whether the guidelines are followed, when applicable. 
General practitioners, who are not member in a network, 
therefore are less bound to evidence-based treatment 
pathways. Other studies showed that being insured in MC 
models is associated with a survival benefit by promoting 
better preventive and higher quality of care.24–26 Espe-
cially among Medicare beneficiaries, which are prone 
to multimorbidity, this effect has been shown.27 These 
models have also shown lower prevalence of potentially 
inappropriate medication use in elderly patients and a 
lower disease-specific hospitalisation rate in patients who 
were chronically ill.16 17
Our study raises the question why patients in limited 
access healthcare models receive a more appropriate diag-
nostic pathway in this clinical situation of stable angina 
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pectoris. There has been evidence for and against the 
theory that patients enrolled in a MC healthcare model 
are healthier due to biased selection28–37 and commercial 
considerations of the MC insurer.38 39 In our study popu-
lation, patients insured in limited access models showed 
some evidence of being healthier than regularly insured 
patients. Nevertheless, being insured only in MC but not 
GK models was independently associated with a higher 
rate of NIIT, controlled for all the differences in patient 
characteristics. It is clear that physicians participating in 
MC models are obliged to keep diagnostic and treatment 
costs as low as possible while keeping up with quality 
concerns. One could therefore argue that it is cheaper 
to not to choose a diagnostic detour over NIIT instead of 
choosing the straight forward way of sending a patient to 
the more invasive CA, which offers a clear answer to an 
uncertain clinical situation including the option of thera-
peutic action. It seems that MC healthcare providers have 
understood what Meara et al have summed up accurately: 
‘Reductions in spending for patients must be a result of 
decreases in the provision of services. If these are needed 
services, quality of care will decline. Alternatively, quality 
of care might be higher in low expenditure areas if differ-
ences in spending result from reductions in unnecessary 
or inappropriate services40’. Besides this intuitive state-
ment, there has been scientific evidence that a diagnostic 
detour is worthwhile taking, since it sums up in reduced 
peri-interventional and postinterventional costs without 
loss in quality.11 Our study is not able to answer the ques-
tions why patients in limited access models received a 
more appropriate diagnostic approach. One can only 
hypothesise that a more rigorous coordination of care, 
as performed in the MC models, is straighter forward 
and the indication for invasive and expensive diagnostic 
procedures is more thoroughly scrutinised.
Determinants for nIIt
Even though simple echocardiography with no stress 
testing does not actually qualify as a NIIT, we chose to 
include this diagnostic procedure due to following 
considerations: some cardiologists might argue that 
patients with dyskinesia in simple echocardiography 
are likely to have relevant coronary pathology therefore 
offering an argument for CA besides the clinical evalua-
tion. Our theory is supported by the ‘2014 ESC/EACTS 
Guidelines on Myocardial Revascularization which state: 
‘regional wall motion abnormalities may be detected in 
simple echocardiography, which increase the likelihood 
of coronary artery disease’.
Since our study lacks clinical data, only indirect hints by 
means of PCG and ATC codes as well as other confounders 
are available to assess clinical reasoning. The associa-
tion between the use of platelet aggregation inhibitors 
or antithrombotic agents and antihypertensive medica-
tion with receiving NIIT before CA suggest a reasonable 
deliberation in the sense of estimating pretest probability 
when deciding on optimal diagnostic strategy. The same 
counts for the association of high-risk status and a larger 
number of chronic comorbidities as determinants for 
not receiving NIIT prior to elective CA. This finding is 
consistent with two US studies indicating that risk stratifi-
cation was performed, considering the higher likelihood 
of a coronary pathology in patients with known coronary 
heart disease.8 10 In our study, also non-clinical factors 
seem to influence decision-making processes concerning 
diagnostic pathways, reflected by the findings that being 
privately insured and a deductible of 2000 SFR were posi-
tively and inpatient treatment negatively independently 
associated with NIIT.
As previously observed in another Swiss study analysing 
inappropriate use of arthroscopic meniscal surgery in 
degenerative knee disease,41 a substantial amount of 
the patients in our sample underwent CA as inpatients 
in contrast to other healthcare settings. This finding is 
most likely explained by differences in the organisation 
of the healthcare system in Switzerland. Here, regional 
governments subsidise inpatient treatment covering 
approximately 50% of total costs, and patients with supple-
mentary private insurance receive a substantially higher 
reimbursement when treated as inpatients. Nevertheless, 
in the regression analysis with the outcome proportion 
of NIIT, we controlled for potential confounders, such as 
inpatient treatment as well. The results therefore seem 
robust concerning the question whether limited access 
healthcare models have a significant impact on the appro-
priateness of the diagnostic approach.
reinforcing quality control mechanisms in a non-gate keeping 
healthcare system
Besides the existing voluntary steering mechanisms such 
limited access healthcare models guided by patient’s 
preferences only, more alternative steering mecha-
nisms have to be implemented in non-GK healthcare 
systems, in order to minimise the influence of non-clin-
ical factors on medical decision making, which might 
lead to inappropriate and possibly dangerous health-
care utilisation as well as increasing expenditures. A 
positive example for alternative steering mechanisms is 
the implementation of national registries42 combined 
with quality initiatives, such as in 2009 published Appro-
priate Use Criteria for Coronary Revascularization.9 42 43 
In 2011, the registry started giving feedbacks on the 
participating hospital’s performance concerning appro-
priateness of CA including a benchmarking against 
other participating institutions. At the same time, 
the American Board of Internal Medicine’s Choosing 
Wisely initiative launched national quality improve-
ment campaigns, identifying CA appropriateness as a 
key area for intervention.44 As a consequence, insur-
ance companies incorporated measures of CA appro-
priateness into pay-for-performance programmes45 and 
reimbursement was declined for certain CA identified 
as inappropriate.46 The combination of implementing 
national registries combined with quality initiatives had 
been proven amazingly effective, showing a decrease of 
non-acute CA classified as inappropriate from 26.2% 
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to 13.3%.47 In Switzerland, currently no registries on 
CA exist, hence other solutions for influencing treat-
ment pathways have to be developed, besides offering 
voluntary limited access healthcare models. A possible 
alternative solution to the conundrum of reducing 
costs without cutting quality seems hence to be paying 
for outcomes instead of volume. As the findings of 
our study suggest, a possible approach is to raise the 
market share of MC to such a volume that it might 
also affect care for fee-for-service patients.40 As Meara 
et al have summarised, the effects have been show to 
play in a variety of ways: more MC in a market might 
lower expenditures by reducing the number of special-
ists, and thereby the number of specialists’ services 
provided48 49 by encouraging more conservative prac-
tice patterns48 49 or by slowing the diffusion of more 
costly technologies.48 50
strengths and limitations
Only scarce data on non-emergency CA exist in liter-
ature. The only data found originates from the USA 
among Medicare as well as commercially insured 
patients and from Switzerland, both non-GK health-
care systems. Whether the proportion of inappropriate 
diagnostic CA from our study can be translated to other 
non-GK healthcare systems is difficult to estimate, since 
substantial variation in the proportion of non-acute 
PCIs considered inappropriate across hospitals can be 
found, ranging from about 6% to 70%.8 10 14 15 47 From a 
previous study from Switzerland,12 similar proportions 
were found, suggesting generalisability of our data. The 
current study seems even more representative than 
the previous Swiss study, since it included data over a 
longer time-period with consecutively larger number of 
patients and corresponding data. Nevertheless, caution 
should be used when generalising to larger populations 
due to the data being limited to only one, even if the 
largest health insurance company in Switzerland, due 
to exclusion criteria and the retrospective study design. 
Since the study is based on insurance claims data, no 
data on socioeconomic status and clinical information 
are available. Given that this is a cross-sectional obser-
vational study, rather than an interventional one, the 
only conclusions that we can draw are of association 
rather than causation. Due to the study design, unfor-
tunately no estimations on clinical outcome parameters 
can be made. For example, in order to explore clin-
ical appropriateness, the proportion of CA’s avoided by 
performing NIIT would be of great interest. As a substi-
tute for clinical data, ATC and PCG are used, offering 
only indirect information on comorbidities. On the 
other hand, PCGs represent a strength, since they have 
been shown to directly correlate with associated health-
care costs.19 Due to data structure, it is not possible to 
distinguish between CT angiography (including intra-
venous contrast) and CT without intravenous contrast. 
Therefore, all CTs of the chest were included in analysis.
COnClusIOn
In a non-GK healthcare system, voluntary MC healthcare 
models with capitation were associated with a reduced 
inappropriate use of diagnostic CA compared with GK or 
basic models.
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